Smoking and treatment outcomes of neovascular age-related macular degeneration over 12 months.

Harshil Dharamdasani DetaramNichole JoachimGerald LiewKim Van VuGeorge BurlutskyPaul MitchellBamini Gopinath

Published in: The British journal of ophthalmology (2019)

Current smoking was associated with a younger age of nAMD onset and key treatment outcomes such as higher mean CMT and greater odds of subretinal fluid presence. These findings suggest that smoking cessation may benefit patients being treated for nAMD.

Keyphrases

smoking cessation
age related macular degeneration
replacement therapy
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis